A phase I/II study of multiple-dose intravenous busulfan as myeloablation prior to stem cell transplantation.

A phase I/II study of multiple-dose intravenous busulfan as myeloablation prior to stem cell transplantation.

Item
http://www.wikidata.org/entity/Q31536804
Hepatic veno-occlusive disease following stem cell transplantation: incidence, clinical course, and outcome.Myeloablative conditioning regimens for AML allografts: 30 years later.Dose-reduced busulfan, cyclophosphamide, and autologous stem cell transplantation for human immunodeficiency virus-associated lymphoma: AIDS Malignancy Consortium study 020.Porous metal organic framework nanoparticles to address the challenges related to busulfan encapsulation.Pharmacokinetics of intravenous busulfan in children prior to stem cell transplantationBusulfan systemic exposure after oral administration of extemporeanously prepared high-dose busulfan capsules.Pharmacokinetics of liposomal busulphan in man.Intravenous busulphan for conditioning before autologous or allogeneic human blood stem cell transplantation.A phase II trial of liposomal busulphan as an intravenous myeloablative agent prior to stem cell transplantation: 500 mg/m(2) as a optimal total dose for conditioning.The effect of metronidazole on busulfan pharmacokinetics in patients undergoing hematopoietic stem cell transplantation.Intravenous busulfan for allogeneic hematopoietic stem cell transplantation in infants: clinical and pharmacokinetic results.Modification of the Bu/Cy myeloablative regimen using daily parenteral busulfan: reduced toxicity without the need for pharmacokinetic monitoring.Population pharmacokinetics of intravenous busulfan in patients undergoing hematopoietic stem cell transplantation.Busulphan-loaded long-circulating nanospheres, a very attractive challenge for both galenists and pharmacologists.Therapeutic drug monitoring is essential for intravenous busulfan therapy in pediatric hematopoietic stem cell recipients
P2860

A phase I/II study of multiple-dose intravenous busulfan as myeloablation prior to stem cell transplantation.

Item
http://www.wikidata.org/entity/Q31536804
description
2000 nî lūn-bûn
@nan
2000 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年学术文章
@wuu
2000年学术文章
@zh-cn
2000年学术文章
@zh-hans
2000年学术文章
@zh-my
2000年学术文章
@zh-sg
2000年學術文章
@yue
name
A phase I/II study of multiple ...... to stem cell transplantation.
@ast
A phase I/II study of multiple ...... to stem cell transplantation.
@en
type
label
A phase I/II study of multiple ...... to stem cell transplantation.
@ast
A phase I/II study of multiple ...... to stem cell transplantation.
@en
prefLabel
A phase I/II study of multiple ...... to stem cell transplantation.
@ast
A phase I/II study of multiple ...... to stem cell transplantation.
@en
P1433
P1476
P2093
P2888
P304
P31
P356
P433
P478
P577
P5875
P6179
P698
P356
P1433
P1476
A phase I/II study of multiple ...... to stem cell transplantation.
@en
P2093
P2888
P304
P31
P356
P433
P478
P577
P5875
P6179
P698